Micro-cognition biomarkers redefine ADHD subtypes

Symptom-based ADHD diagnoses may not align with a patient’s underlying neuropathy, making it harder to develop individualized treatment plans. In a new study published in Psychiatry Research, a team led by Yale School of Medicine’s Bruce Wexler, MD, identified four ADHD subgroups based on biomarkers observed during digital neurotherapy.

Read More

Mitochondrial Dysfunction May Be Important Biomarker for ADHD, ASD

Researchers have identified a “significant relationship” between higher mitochondrial DNA copy number (mtDNA-cn) and the occurrence of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Results from the systematic review and meta-analysis were published in the journal Frontiers in Psychiatry.

Read More

We Need Adult ADHD Guidelines and Objectivity

KEY POINTS: Untreated or undiagnosed ADHD can lead to more serious problems, but ADHD is highly treatable. ADHD rarely exists alone: 75 percent of patients have at least one comorbidity; 60 percent have two or more. Objective and subjective measures work together across medicine—and they should for ADHD as well.

Read More

Health Talk: Self-diagnosing ADHD

In today’s Health Talk, we’re breaking down information on some parents and experts expressing alarm over teens self-diagnosing themselves with ADHD. Dr. Justin Schreiber from UPMC Children’s Hospital of Pittsburgh joined us in studio.

Read More

Managing Summer Screen Time for Kids with ADHD

KEY POINTS: Don’t let your kids play video games 24/7 this summer. Worry less about the time spent on screens and more about getting kids outdoors and with other people. Creatively use tech tools to encourage physical, social, and creative play. Screen time is easy, parenting is not.

Read More